Investigational Site Number : 1520001

Temuco 4800827

1 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma, Plasma Cell Myeloma Recurrent

Studies at this site

• International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab — Enrolling by invitation
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling